Table 1.
Immune cells | Common markers for identification | Association with poor prognosis | Functions associated with liver cancer |
---|---|---|---|
Neutrophils/TANs | CD11b, CD66b, Ly6G | High population10 | Inflammatory responses,20 macrophage recruitment26 |
Macrophages/TAMs | iNOS, CD80, and CD86 for M1 subsets and CD163, CD204, and CD206 for M2 | High population10 | Inflammatory responses and cytokine secretion26,27,35,36 |
MDSCs | CD33, CD45 | High population48,49 | Monocyte recruitment,50 immunosuppression51 |
DCs | HLA-DR | May differ depending on activation or localization57,59 | Regulation of T-cell cytotoxic activity60,61 |
NK cells | CD27, NKG2D | Low population68 | IFN-γ production,67 anti-tumor cytotoxicity69,70 |
B cells | CD20, CD79a | Low population75 | Promotion of T-cell activation78 |
T cells | CD3, CD4, CD8 | Low population79,80 | Cytotoxic activity against tumor cells79, 80, 81 |
Tregs | FOXP3 | High population10 | Immunosuppression87 |
Th17 cells | CD3+CD4+CD8− | High population92 | Suggested close relationship with Tregs92,93 |
Mast cells | c-Kit, chymase, tryptase | Controversial98,99 | Histamine secretion95 |
c-Kit, receptor tyrosine kinase; DC, dendritic cell; FOXP3, forkhead box P3; HLA-DR, major histocompatibility complex class II DR; IFN, interferon; iNOS, inducible nitric oxide synthase; Ly6G, lymphocyte antigen 6 complex locus G; MDSC, myeloid-derived suppressor cell; NK, natural killer; NKG2D, NK group 2 member D; TAM, tumor-associated macrophage; TAN, tumor-associated neutrophil; Th17, type 17 helper T; Treg, regulatory T cell.